{"id":"https://openalex.org/W2010142891","doi":"https://doi.org/10.1097/00005344-200010000-00007","title":"Raloxifene and Estrogen Inhibit Neointimal Thickening After Balloon Injury in the Carotid Artery of Male and Ovariectomized Female Rats","display_name":"Raloxifene and Estrogen Inhibit Neointimal Thickening After Balloon Injury in the Carotid Artery of Male and Ovariectomized Female Rats","publication_year":2000,"publication_date":"2000-10-01","ids":{"openalex":"https://openalex.org/W2010142891","doi":"https://doi.org/10.1097/00005344-200010000-00007","mag":"2010142891","pmid":"https://pubmed.ncbi.nlm.nih.gov/11026646"},"language":"en","primary_location":{"id":"doi:10.1097/00005344-200010000-00007","doi":"https://doi.org/10.1097/00005344-200010000-00007","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00005344-200010000-00007","pdf_url":null,"source":{"id":"https://openalex.org/S61167191","display_name":"Journal of Cardiovascular Pharmacology","issn_l":"0160-2446","issn":["0160-2446","1533-4023"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Cardiovascular Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5006900371","display_name":"Raymond F. Kauffman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Raymond F. Kauffman","raw_affiliation_strings":["Cardiovascular Discovery, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, USA","Cardiovascular Discovery, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, U.S.A","Received March 8, 2000","revision accepted June 27, 2000"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cardiovascular Discovery, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, USA","institution_ids":["https://openalex.org/I168537998"]},{"raw_affiliation_string":"Cardiovascular Discovery, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, U.S.A","institution_ids":["https://openalex.org/I168537998"]},{"raw_affiliation_string":"Received March 8, 2000","institution_ids":[]},{"raw_affiliation_string":"revision accepted June 27, 2000","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066150506","display_name":"James S. Bean","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James S. Bean","raw_affiliation_strings":["Cardiovascular Discovery, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, U.S.A","and reprint requests to Dr. R. F. Kauffman at Cardiovascular Research, Lilly Research Laboratories, Lilly Corporate Center 0522, Indianapolis, IN 46285, U.S.A","Received March 8, 2000","revision accepted June 27, 2000"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cardiovascular Discovery, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, U.S.A","institution_ids":["https://openalex.org/I168537998"]},{"raw_affiliation_string":"and reprint requests to Dr. R. F. Kauffman at Cardiovascular Research, Lilly Research Laboratories, Lilly Corporate Center 0522, Indianapolis, IN 46285, U.S.A","institution_ids":["https://openalex.org/I168537998"]},{"raw_affiliation_string":"Received March 8, 2000","institution_ids":[]},{"raw_affiliation_string":"revision accepted June 27, 2000","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044150692","display_name":"Kennan J. Fahey","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kennan J. Fahey","raw_affiliation_strings":["Cardiovascular Discovery, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, U.S.A","and reprint requests to Dr. R. F. Kauffman at Cardiovascular Research, Lilly Research Laboratories, Lilly Corporate Center 0522, Indianapolis, IN 46285, U.S.A","Received March 8, 2000","revision accepted June 27, 2000"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cardiovascular Discovery, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, U.S.A","institution_ids":["https://openalex.org/I168537998"]},{"raw_affiliation_string":"and reprint requests to Dr. R. F. Kauffman at Cardiovascular Research, Lilly Research Laboratories, Lilly Corporate Center 0522, Indianapolis, IN 46285, U.S.A","institution_ids":["https://openalex.org/I168537998"]},{"raw_affiliation_string":"Received March 8, 2000","institution_ids":[]},{"raw_affiliation_string":"revision accepted June 27, 2000","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009397956","display_name":"George J. Cullinan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"George J. Cullinan","raw_affiliation_strings":["Cardiovascular Discovery, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, U.S.A","and reprint requests to Dr. R. F. Kauffman at Cardiovascular Research, Lilly Research Laboratories, Lilly Corporate Center 0522, Indianapolis, IN 46285, U.S.A","Received March 8, 2000","revision accepted June 27, 2000"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cardiovascular Discovery, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, U.S.A","institution_ids":["https://openalex.org/I168537998"]},{"raw_affiliation_string":"and reprint requests to Dr. R. F. Kauffman at Cardiovascular Research, Lilly Research Laboratories, Lilly Corporate Center 0522, Indianapolis, IN 46285, U.S.A","institution_ids":["https://openalex.org/I168537998"]},{"raw_affiliation_string":"Received March 8, 2000","institution_ids":[]},{"raw_affiliation_string":"revision accepted June 27, 2000","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"David A. Cox","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David A. Cox","raw_affiliation_strings":["Cardiovascular Discovery, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, U.S.A","and reprint requests to Dr. R. F. Kauffman at Cardiovascular Research, Lilly Research Laboratories, Lilly Corporate Center 0522, Indianapolis, IN 46285, U.S.A","Received March 8, 2000","revision accepted June 27, 2000"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cardiovascular Discovery, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, U.S.A","institution_ids":["https://openalex.org/I168537998"]},{"raw_affiliation_string":"and reprint requests to Dr. R. F. Kauffman at Cardiovascular Research, Lilly Research Laboratories, Lilly Corporate Center 0522, Indianapolis, IN 46285, U.S.A","institution_ids":["https://openalex.org/I168537998"]},{"raw_affiliation_string":"Received March 8, 2000","institution_ids":[]},{"raw_affiliation_string":"revision accepted June 27, 2000","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5038157962","display_name":"William R. Bensch","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William R. Bensch","raw_affiliation_strings":["Cardiovascular Discovery, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, U.S.A","and reprint requests to Dr. R. F. Kauffman at Cardiovascular Research, Lilly Research Laboratories, Lilly Corporate Center 0522, Indianapolis, IN 46285, U.S.A","Received March 8, 2000","revision accepted June 27, 2000"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cardiovascular Discovery, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, U.S.A","institution_ids":["https://openalex.org/I168537998"]},{"raw_affiliation_string":"and reprint requests to Dr. R. F. Kauffman at Cardiovascular Research, Lilly Research Laboratories, Lilly Corporate Center 0522, Indianapolis, IN 46285, U.S.A","institution_ids":["https://openalex.org/I168537998"]},{"raw_affiliation_string":"Received March 8, 2000","institution_ids":[]},{"raw_affiliation_string":"revision accepted June 27, 2000","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5006900371"],"corresponding_institution_ids":["https://openalex.org/I168537998"],"apc_list":null,"apc_paid":null,"fwci":1.9443,"has_fulltext":false,"cited_by_count":23,"citation_normalized_percentile":{"value":0.84987361,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"36","issue":"4","first_page":"459","last_page":"465"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10756","display_name":"Estrogen and related hormone effects","score":0.9911999702453613,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10756","display_name":"Estrogen and related hormone effects","score":0.9911999702453613,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11618","display_name":"Cholesterol and Lipid Metabolism","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10686","display_name":"Effects and risks of endocrine disrupting chemicals","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2307","display_name":"Health, Toxicology and Mutagenesis"},"field":{"id":"https://openalex.org/fields/23","display_name":"Environmental Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/raloxifene","display_name":"raloxifene","score":1.0},{"id":"https://openalex.org/keywords/ethinyl-estradiol","display_name":"ethinyl estradiol","score":0.9750000238418579},{"id":"https://openalex.org/keywords/neointimal-thickening","display_name":"neointimal thickening","score":0.871999979019165},{"id":"https://openalex.org/keywords/balloon-injury","display_name":"balloon injury","score":0.9049999713897705},{"id":"https://openalex.org/keywords/carotid-artery","display_name":"carotid artery","score":0.9779999852180481},{"id":"https://openalex.org/keywords/estrogen-receptor","display_name":"estrogen receptor","score":0.9089999794960022},{"id":"https://openalex.org/keywords/fulvestrant","display_name":"fulvestrant","score":0.9729999899864197},{"id":"https://openalex.org/keywords/ovariectomy","display_name":"ovariectomy","score":0.8109999895095825},{"id":"https://openalex.org/keywords/sex-differences","display_name":"sex differences","score":0.7699999809265137},{"id":"https://openalex.org/keywords/serum-cholesterol","display_name":"serum cholesterol","score":0.6729999780654907}],"concepts":[{"id":"https://openalex.org/C2779889926","wikidata":"https://www.wikidata.org/wiki/Q425223","display_name":"Raloxifene","level":5,"score":0.9642795324325562},{"id":"https://openalex.org/C8264082","wikidata":"https://www.wikidata.org/wiki/Q7113259","display_name":"Ovariectomized rat","level":3,"score":0.8491718769073486},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7047101259231567},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.654297411441803},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.643802285194397},{"id":"https://openalex.org/C2777164284","wikidata":"https://www.wikidata.org/wiki/Q277954","display_name":"Estrogen","level":2,"score":0.639930784702301},{"id":"https://openalex.org/C2777944059","wikidata":"https://www.wikidata.org/wiki/Q903917","display_name":"Selective estrogen receptor modulator","level":5,"score":0.634616494178772},{"id":"https://openalex.org/C84606932","wikidata":"https://www.wikidata.org/wiki/Q416496","display_name":"Estrogen receptor","level":4,"score":0.4853031039237976},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.42806434631347656},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.33786866068840027},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.25011759996414185},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.0},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000077267","descriptor_name":"Fulvestrant","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002404","descriptor_name":"Catheterization","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002784","descriptor_name":"Cholesterol","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D004958","descriptor_name":"Estradiol","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D004958","descriptor_name":"Estradiol","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004965","descriptor_name":"Estrogen Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004997","descriptor_name":"Ethinyl Estradiol","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010052","descriptor_name":"Ovariectomy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020212","descriptor_name":"Carotid Artery Injuries","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D020849","descriptor_name":"Raloxifene Hydrochloride","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/00005344-200010000-00007","doi":"https://doi.org/10.1097/00005344-200010000-00007","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00005344-200010000-00007","pdf_url":null,"source":{"id":"https://openalex.org/S61167191","display_name":"Journal of Cardiovascular Pharmacology","issn_l":"0160-2446","issn":["0160-2446","1533-4023"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Cardiovascular Pharmacology","raw_type":"journal-article"},{"id":"pmid:11026646","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11026646","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of cardiovascular pharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.47999998927116394}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":36,"referenced_works":["https://openalex.org/W44269886","https://openalex.org/W56648938","https://openalex.org/W1492488087","https://openalex.org/W1565310327","https://openalex.org/W1904176703","https://openalex.org/W1966323574","https://openalex.org/W1970028985","https://openalex.org/W1985311184","https://openalex.org/W1992827635","https://openalex.org/W1997883187","https://openalex.org/W1998874599","https://openalex.org/W2005831605","https://openalex.org/W2008039212","https://openalex.org/W2011951689","https://openalex.org/W2020658832","https://openalex.org/W2028756696","https://openalex.org/W2031145414","https://openalex.org/W2031716151","https://openalex.org/W2040530673","https://openalex.org/W2049557838","https://openalex.org/W2055164718","https://openalex.org/W2073967278","https://openalex.org/W2075186943","https://openalex.org/W2078676166","https://openalex.org/W2083578330","https://openalex.org/W2094924746","https://openalex.org/W2112590471","https://openalex.org/W2112629831","https://openalex.org/W2114868315","https://openalex.org/W2116726063","https://openalex.org/W2141991871","https://openalex.org/W2157209694","https://openalex.org/W2158683428","https://openalex.org/W2168300710","https://openalex.org/W2255063552","https://openalex.org/W2615633554"],"related_works":["https://openalex.org/W2040530673","https://openalex.org/W2320430442","https://openalex.org/W2001540601","https://openalex.org/W2166424349","https://openalex.org/W2080697629","https://openalex.org/W2348113136","https://openalex.org/W2390078515","https://openalex.org/W2027018246","https://openalex.org/W2361222622","https://openalex.org/W2391838162"],"abstract_inverted_index":{"The":[0,57],"effects":[1,171],"of":[2,51,59,88,101,111,149,187],"raloxifene":[3,28,61,105,112,136,159],"and":[4,20,29,54,106,115,128,139,151,160,181],"17alpha-ethinyl":[5],"estradiol":[6],"(EE2)":[7],"on":[8,172],"intimal":[9,41,80,124,144],"thickening":[10,42,81,125,145],"in":[11,18,36,43,166],"response":[12,44],"to":[13,45,48,62,78,119,146],"balloon":[14,46,102,163],"injury":[15,47,103,165],"were":[16],"tested":[17],"male":[19,25],"ovariectomized":[21,132],"female":[22,133],"rats.":[23],"In":[24,131],"rats,":[26,134],"oral":[27,60,135],"EE2,":[30,161],"administered":[31],"either":[32],"by":[33,104,126],"gavage":[34],"or":[35,70,83],"the":[37,89,99,120,167,173,178],"diet,":[38],"inhibited":[39,123,143],"arterial":[40,164],"a":[49,147],"maximum":[50,148],"approximately":[52],"60":[53],"50%,":[55],"respectively.":[56,130,153],"effect":[58],"decrease":[63],"cholesterol":[64],"was":[65],"observed":[66],"at":[67,183],"doses":[68],"(>":[69,82],"=":[71,84],"3":[72],"mg/kg/day)":[73,114,118,138,142],"higher":[74],"than":[75],"those":[76],"required":[77],"inhibit":[79,162],"0.03":[85],"mg/kg/day).":[86],"Coadministration":[87],"estrogen":[90,179],"receptor":[91,180],"antagonist,":[92],"ICI":[93],"182,780":[94],"(5":[95],"mg/kg/day,":[96],"s.c.),":[97],"blocked":[98],"inhibition":[100],"EE2.":[107],"Direct":[108],"adventitial":[109],"delivery":[110],"(0.03":[113],"EE2":[116,140],"(0.001":[117],"vascular":[121,174],"wall":[122,175],"63":[127],"53%,":[129],"(0.01-3.0":[137],"(0.08":[141],"32":[150],"60%,":[152],"Together,":[154],"these":[155],"data":[156],"suggest":[157],"that":[158,176],"rat":[168],"through":[169],"direct":[170],"involve":[177],"are":[182],"least":[184],"partially":[185],"independent":[186],"serum":[188],"cholesterol.":[189]},"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}